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The rapid  activation of Hageman  factor (HF) 1 which occurs when  plasma comes 
into contact  with  a  negatively charged  surface,  results  from  the  interaction  of HF 
with high molecular weight kininogen and prekallikrein  (1). Under these conditions, 
rapid proteolytic cleavage of each of these molecules takes place as HF and prekalli- 
krein  are  converted  from  zymogen  to  active  enzyme  (1-3). 2 However,  the  critical 
question of what provides the triggering event leading to reciprocal activation between 
surface-bound HF and prekallikrein  has not been answered. 
Early studies pointed to the possibility that HF might become activated by merely 
binding to the  negatively charged surface and  thereby  undergoing some conforma- 
tional change which exposed an active site  (4-10).  Ratnoff and Saito  (11)  have also 
recently  suggested  that  Sephadex-Ellagic  acid  mixtures  may  activate  HF  without 
proteolytic modification. That conformational changes do occur in surface-bound HF 
was supported by finding increased hydrophobicity (12) and a change in the circular 
dichromatic  spectum  (13)  of HF  upon  binding  to  negatively  charged  substances. 
Other workers, however, have concluded that binding of HF to a surface per se, is not 
alone sufficient to activate the molecule but that limited cleavage is also required for 
HF  activation.  In  plasmas  which  are  deficient  in  prekallikrein  or  high  molecular 
weight  kininogen,  the  HF binds  to added  negatively charged particles  at  the same 
rate  as  it  does in  normal  plasma,  but  is only slowly cleaved and  activated  (1).  The 
uptake of [SH]diisopropylfluorophosphate (DFP) into zymogen HF occurs only slowly, 
and this slow rate of incorporation remains unchanged when the HF is surface bound 
(14,  15).  Using purified  components,  bovine single-chain  HF,  unlike  the  two chain 
form, is not procoagulant  (16)  and the rapid activation of surface-bound HF is only 
achieved in the presence of prekallikrein  and high MW kininogen  (17-19).  Thus, it 
appears to be the assembly of this complex of molecules on the surface (20)  that leads 
to the normal rapid burst of activity of HF which is associated with activation of the 
contact system. 
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Therefore, although  the reciprocal activation between HF and kallikrein accounts 
for the rapid activation of these enzymes, the initial triggering event which leads to 
conversion  of zymogen  to  enzyme  remains  obscure.  Because  HF  activation  does 
proceed, albeit slowly, in prekallikrein-deficient plasma (1, 21), we have explored the 
possibility that  zymogen  HF might  be capable of activating other HF molecules in 
the absence of prekallikrein. 
Materials  and  Methods 
Purificatwn of Proteins  from Rabbtt Plasma.  HF and a-HF, were purified from citrated rabbit 
plasma by combined affinity and ion-exchange chromatography as described elsewhere.  3 The 
preparations of purified HF and a-HFa used for the experiments described are shown in Fig. 1. 
Factor XI  was  purified by ion-exchange chromatography from  rabbit  plasma as described 
elsewhere  (22).  Prekallikrein, kindly provided by  Dr.  Richard  Ulevitch, was  purified  from 
rabbit plasma as described elsewhere (23). Both factor XI and prekallikrein were homogeneous 
single protein bands on polyacrylamide gel electrophoresis in the presence of sodium dodecyl 
sulfate (SDS). High molecular weight kininogen was purified from rabbit plasma as previously 
reported for human high molecular weight kininogen (20). 
SDS-Polyac~ylamide GelElectrophoresis.  SDS-polyacrylamide  slab gels were prepared according 
to Laemmli (24).  Reactions were stopped by boiling in the presence of 2% SDS and 2.5%/~- 
mercaptoethanol. The running gels (9% aerylamide) were fixed, dried in a slab gel drier (Hoefer 
Scientific Instruments,  San Francisco, Calif.) and  placed on  Kodak X-omat  film (Eastman- 
Kodak Co., Rochester, N. Y.) to localize the radioactive protein. The radioactivity on the gel 
was quantitated by cutting up the gel and counting the radioactivity in the regions indicated 
by the autoradiogram. These results were expressed as the percent change in the proportion of 
radioactivity present  at  native  molecular weight.  In  all  experiments,  at  least  80%  of the 
radioactivity was present at the native molecular weight. 
Experimental Protocols 
PROTEOLYTIC CLEAVAGE  OF  KAOLIN-BOUND DFP-TREATED HF  IN  THE  PRESENCE  AND  ABSENCE OF 
DFP.  All reagents used were freshly prepared using water filtered by a  Barnstead Nanopure 
system (Barnstead Co., Sybron Corp., Boston, Mass.). Kaolin (400 #g) was washed three times 
in 1 ml of 0.1 M Tris, pH 7.4. HF (2.4 #g plus 125I-HF, 1 pg, 0.7/~Ci) was added to 10 pl of 0.1 
M  Tris buffer, pH 7.4. 15 pl of 50 mM DFP (Calbiochem-Behring Corp., American Hoechst 
Corp., San Diego, Calif.) in water (total vol 60/~1) was added to this mixture. After 5 min at 
22°C, the HF-DFP mixture was added to the washed kaolin and incubated for a further 5 min 
at 22°C. This mixture was then split into two halves. The kaolin in one-half was washed as 
previously described in 0.1  M  Tris buffer containing 5  mM  DFP and  the second half was 
washed with 0.1 M Tris buffer alone. Each kaolin sample was washed four times in 1 ml of cold 
buffer and separated by centrifugation at  12,000 g for I min. After the last wash, the samples 
were suspended in 60 #1 of either 0.1  M  Tris buffer pH 7.4 alone or 0.1  M  Tris buffer pH 7.4 
containing 5 mM DFP. Samples were placed in a water bath at 37°C and at the times shown 
in Fig. 4, aliquots were removed for analysis on SDS-polyacrylamide gels. 
EFFECT  OF  PROLONGED  INCUBATION WITH  DFP  ON  CLEAVAGE  OF  KAOLIN-BOUND I-IF.  DFP (50 
mM in water) was added to HF (1.6 pg plus 0.5 pg 125I-HF) in the presence of 1 M Tris pH 7.4 
to a final concentration of 20 mM DFP in a plastic 1.5 ml capped tube. Samples were incubated 
for 48 and 6 h at 37°C and for 24, 4, and 0 h at 22°C. For the samples incubated more than 
4 h, DFP was added to the incubation mixture twice every 24 h. The pH was maintained by 
addition of 1 M Tris buffer. For each HF sample an identically treated sample of 0.1 M acetate 
buffer pH 5.0 (the buffer against which the HF and 125I-HF had previously been dialyzed) was 
incubated  (hereafter called DFP control). A  20-/d subsample of each  HF and  DFP-control 
mixture was removed and  added to  180/~1 of Tris-buffered saline containing bovine serum 
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Fxo.  l.  SDS-polyacrylamide  gel analysis of the preparation of purified single-chain HF and the 
two-chain 82,000 mol wt form of activated Hageman factor (a-HFa) used for the studies described. 
Before electrophoresis, samples (30 /xg protein) were boiled with sodium dodecyl sulfate (2%). 
Reduction was effected with/3-mercaptoethanol (2%). 
albumin (BSA)  (1  mg/ml). The HF procoagulant activity was measured using human HF- 
deficient plasma. The clotting times were compared to a standard curve that was constructed 
using dilutions  of normal citrated rabbit plasma. An adjustment for residual DFP was made by 
measuring the prolongation of the clotting time caused by the DFP-control solution on a  1/10 
dilution of normal rabbit plasma. The proportion of HF procoagulant activity present was 
calculated on the basis of non-DFP-treated HF having a  value of 100%. That no significant 
(<15%)  loss of HF occurred during the incubation procedure was confirmed by measuring the 
recovery of radioactivity. The  DFP-treated  HF  mixture, from  which  a  10 #1  aliquot  had 
previously been removed for analysis on SDS-polyacrylamide gels (control), was added to 200 
#g of kaolin. The kaolin was resuspended in the HF-containing  solution for 5 min at 22°C. The 
kaolin was then washed four times with 0.1  M  Tris buffer, by centrifugation at  12,000 g, to 
remove the DFP and non-bound HF (-30% of 125I-HF bound to kaolin). After washing, the 
kaolin was suspended in 60 #1 of 0.1 M Tris buffer and a 20-#1 aliquot was removed for SDS- 
polyacrylamide gel analysis. The remaining kaolin was incubated at 37°C for 35 min and then 
a final 20 #1 aliquot was removed for analysis by SDS-polyacrylamide gel electrophoresis.  The 
extent of proteolytic cleavage of 125I-HF was  calculated as  the  proportion of radioactivity 
remaining in the  native 82,000  dalton band in relation to  the control removed before the 
addition of kaolin for each sample (81-86% of the radioactivity in the gel). 
PREPARATION OF NORMAL  HUMAN  PLASMA  AND  PREKALLIKREIN-DEFICIENT PLASMA  DEPLETED OF 
Hr.  The  IgG  fraction  of normal  goat  globulin or  goat-anti-human HF  was  coupled  to 
Sepharose 4B  (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) by the 
cyanogen bromide method (25). The beads were suspended in 0.1 M Tris 0.15 M NaC1, pH 7.4 
so that 80% of the settled volume consisted of beads. Normal human plasma or prekallikrein- 
deficient plasma (140 #1) was incubated with an equal volume of the beads for 20 min at 22°C, 
and then separated by centrifugation at  12,000 g for 2 min. The plasmas absorbed with anti- 
HF beads contained 10%  of the amount of HF present in the plasma absorbed with goat 
globulin beads as measured by clotting assay in human HF-deficient plasma. An aliquot of the 
HF-depleted plasmas were then reconstituted to  the same HF-content as the  goat-globulin 
absorbed plasma by addition of purified human HF (provided by Ms. Susan Revak, Depart- 
ment of Immunopathology, Scripps Clinic and Research Foundation), as assessed by clotting 
assay. 
lzSI-rabbit  HF (5 #1, 400 ng, 0.5 btCi) was added to 50 #1 of each plasma-diluted one-half in 
Tris-buffered saline. Kaolin (4 #1,  200 #g)  was  added  to  the  plasma and subsamples were 
withdrawn for analysis by polyacrylamide gel electrophoresis at 0,  1, 2, 8, and 20 min. The 
results are expressed  as the percent 12SI-HF  cleaved from the native 82,000 dalton band at each 
time point compared with the 0 time point for each plasma. 
Miscellaneous.  Radiolabeling  of protein with  I was performed by the chloramine-T  method 
(26) to a  specific  activity of 0.5 #Ci/#g. BSA (recrystalized five times), was purchased from 
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Fxc.  2.  The rate of proteolytic cleavage of ]25I-HF  incubated at  37°C  in solution  (A),  in the 
presence of kaolin (A), in the presence of kaolin plus prekallikrein (O),  in the presence of kaolin, 
prekallikrein, and high molecular weight kininogen (F'I). 
Results 
Proteolytic Cleavage of HF in the Presence and Absence of Kaolin, Prekallikrein, and High 
Molecular Weight Kininogen.  The effect of kaolin (100/zg), prekallikrein (0.8/~g), and 
high molecular weight kininogen (1.5/zg)  upon the proteolytic cleavage of I~SI-HF 
(300 ng, 0.4/~Ci plus HF 1.2/zg)  in a purified system (120/zl) containing 0.1 M Tris, 
pH  7.6  (20 ~1)  and BSA  (20/zg)  was studied  (Fig.  2).  Incubation of HF alone in 
solution for 30 min at physiological concentration (12/~g/ml) resulted in no detectable 
cleavage of 125I-HF. However, when kaolin was added to this incubation mixture, 
proteolytic cleavage of 125I-HF did occur so that in a typical experiment, as shown in 
Fig. 2, 16% of the molecules were cleaved after 30 min. This observation has also been 
made with human HF in the presence of both glass and kaolin. The rate of cleavage 
of 125I-HF was enhanced -  10-fold when prekallikrein (6.5/zg/ml) was present in the 
incubation mixture, and further enhanced when high molecular weight kininogen (12 
#g/ml) was also present. In parallel experiments, radiolabeled prekallikrein and factor 
XI  did not undergo proteolytic cleavage when incubated alone in the presence or 
absence of kaolin. However, rapid cleavage of both these molecules was observed in 
the presence of kaolin when HF was present in the reaction mixture. 
The cleavage pattern of ~25I-HF observed on autoradiography was the same for all 
experiments described in this report.  The 82,000  dalton native HF was cleaved to 
fragments which migrated with apparent mol wt of 50,000 and 28,000  dahons in the 
presence of reducing agent. 
Proteolytic Cleavage of HF  by  a-HF,.  Because  HF  appeared  to  be  capable  of 
undergoing slow proteolytic cleavage in the presence of kaolin alone, we considered 
the possibility that the two-chain form of activated HF (a-HFa) might proteolytically 
cleave single-chain HF. To assess this, purified HFa (100 #g/ml and serial dilutions 
thereof in 10 ~tl 0.01 M acetate buffer, pH 5) was incubated with 125I-HF (800 ng HF) 
in the presence and absence of kaolin (250 ~g), and the extent of proteolytic cleavage 
of the I~I-HF after a  10-min incubation at 37°C was measured by SDS-polyacryl- 
amide gel electrophoresis.  Even  at  high concentrations of a-HF~  (50 ~g/ml), <5% 
cleavage of 125I-HF occurred in solution. In contrast, in the presence of kaolin, 125I-HF 
was cleaved in a  dose-related fashion. At 50, 25,  12.5, 6.25, 3.13,  and  1.6/~g/ml the 
extent of cleavage of lz~I-HF  observed was 42, 47,  29,  18, 8, and  2%, respectively. 
Thus, a-HF~ appeared to be capable of proteolytically cleaving HF, in the presence 
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FIG.  3.  The rate ofproteolytic cleavage of kaolin-bound diisopropylfluorophosphate (DFP)-treated 
HF incubated in the presence (O)  and absence (A) of 5 mM DFP. 
Inhibition of a-HFa by Soybean T~ypsin Inhibitor (SBTI) and DFP.  Because cleavage of 
HF by the a-HFa preparation could have been a result of a contaminating protease, 
the ability of SBTI and  DFP  to inhibit  a-HFa-mediated cleavage of prekallikrein, 
factor XI and HF were compared, a-HF, (4/~g)  was incubated with SBTI in 0.1  M 
Tris, pH 7.4, in various amounts (2, 0.5, 0.125, 0.03, and 0 #g) for I0 min at 22°C in 
a total 80-/~1 vol. 12SI-HF (50 ng) or 12sI-factor XI (45 ng) was added to kaolin (50 #g) 
in Tris-buffered saline,  a25I-prekallikrein  (50 ng)  was  added  to an equal  volume of 
Tris-buffered saline containing 1 mg/ml BSA. To plastic tubes containing 10 #1 of 0. l 
M  Tris buffer pH 7.4 and the above mixture of radiolabeled proteins, a  10-/~1 aliquot 
of the a-HFa/SBTI reaction mixture was added (500 ng ofa-HFa plus 250, 62.5, 15.6, 
3.9,  or 0  ng  SBTI).  After a  10-min  incubation  at  37°C  the  extent  of proteolytic 
cleavage  of  the  radiolabeled  protein  was  measured  by  SDS-polyacrylamide  gel 
electrophoresis. Compared  to the control  (no SBTI), the SBTI-treated a-HF~  (3.9, 
15.6, 62.5, and 250 ng SBTI +  500 ng a-HF,) cleaved, respectively, factor XI (90, 58, 
24,  and 6%), HF (79, 52,  18, and 5%) and prekallikrein  (70,  48,  15, and 5%). Thus, 
SBTI inhibited a-HF~-mediated cleavage of factor XI,  HF,  and  prekallikrein  in  a 
dose-related fashion and  to a  similar extent, indicating  that  the same enzyme was 
responsible for their cleavage. In a similar experiment, preincubation of ~-HFa with 
DFP (2 mM for 10 min at 22°C) completely inhibited the observed a-HFa-mediated 
cleavage of radiolabeled HF, factor XI, and prekallikrein. 
Proteolytic Cleavage of Kaolin-bound HF in the Presence and Absence of DFP.  Incubation 
of single-chain HF with kaolin resulted in slow proteolytic cleavage of HF molecules 
(Fig.  2).  Such  cleavage  could  have  been  caused  either  by  the  HF  preparation 
containing a small proportion of a-HFa or by some other contaminating protease. To 
investigate this possibility, HF was preincubated with DFP (12 mM) to inhibit active 
serine  protease  enzymes.  Kaolin  was  then  added  to  this  mixture  to  inhibit  any 
enzymes possibly associated with the kaolin  (see  Methods for details).  The mixture 
was then divided into two equal aliquots. The kaolin-bound HF in one aliquot was 
washed in 0.1  M  Tris buffer to remove DFP and nonbound HF;  the kaolin-bound 
HF in the second aliquot was washed in 0. I  M  Tris buffer containing 5 mM DFP. 
Both preparations of kaolin-bound HF were then incubated at 37°C and the rate of 
proteolytic cleavage of 12~I-HF measured by analysis of SDS-polyacrylamide gels. One 
of three similar experiments is shown in Fig. 3; rapid proteolytic cleavage occurred in 
the reaction mixture from which DFP had been removed by washing, but not in the 
reaction  mixture  in  which  DFP  was  present.  Thus,  although  the  observed  rapid 
cleavage of HF  was  caused  by an  enzyme that  was  sensitive to  DFP,  the enzyme R. C. WIGGINS  AND  C. C. COCHRANE  1127 
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Fzo. 4.  The effect of prolonged preincubation of HF with DFP, resulting in inhibition of HF 
procoagulant activity by 78.2% (A), 67.2% (C)), 39.4% (I-I), 30.6% (&), and 0% (0) upon the rate of 
cleavage of kaolin-bound 125I-HF. 
could not be blocked by prior incubation with DFP. In addition, even in the presence 
of a  10,000-fold molar excess of DFP cleavage of HF was  not  inhibited altogether 
(Fig.  3).  In  fact, proteolytic cleavage under these conditions proceeded in  a  linear 
fashion so that ~9% of the 125I-HF molecules were cleaved after 90 rain, or O. 1%/rain. 
A catalyst which was resistant to short-term DFP treatment must therefore have been 
present in the HF preparation. 
The Effect of Prolonged  Incubation of HF with DFP.  Because zymogen single-chain HF 
slowly takes up and is inactivated by DFP (14, 15), the effect of prolonged incubation 
of HF with DFP on cleavage of kaolin-bound HF was measured. After incubation of 
HF for 48 h at 37°C with  10 mM DFP, only 21.8% of the HF procoagulant activity 
remained.  Shorter incubations  with  DFP at  37  or 22°C  (Methods)  resulted in  less 
inhibition  of HF  procoagulant  activities  (32.8,  60.6,  69.4,  and  100%  HF activity 
remaining). Kaolin was added to these HF preparations and subsequently washed to 
remove  DFP  and  nonbound  HF  (Methods).  The  extent  of a2nI-HF  cleavage  was 
measured by SDS-polyacrylamide gel analysis immediately after the washing proce- 
dure and after a further 35-rain incubation at 37°C. As shown in Fig. 4, the rate and 
extent of cleavage of x25I-HF varied with the amount of inhibition of procoagulant 
activity by DFP. Thus, HF which had been extensively inhibited by DFP underwent 
less proteolytic cleavage than HF which had not been inhibited by DFP. Although 
the true initial rates of cleavage of kaolin-bound HF cannot be calculated from these 
data,  a  plot  of the  proportions  of HF  cleaved  (after the  25-min  period  of kaolin 
washing)  against  the proportion of remaining HF procoagulant activity on a  linear 
scale (Fig. 5) suggests that at 0 procoagulant activity there would be no cleavage of 
HF. Such a relationship is consistent with the concept that it is single-chain HF which 
is responsible for HF cleavage, and not a contaminating DFP-insensitive enzyme. 
The Effect of Varying the Kaolin Concentration upon Cleavage of HF.  From the preceding 
experiment, it  appeared  that  single-chain  HF was  capable of undergoing cleavage 
upon contact with kaolin. We then questioned whether cleavage could occur either 
from simple interaction of the HF with kaolin or alternatively by the action of HF 
molecules upon other HF molecules, converting them  into the two-chain form. To 
differentiate between  these  possibilities,  the  amount  of negatively charged  surface 
(kaolin)  was  varied over an  extensive range,  resulting in  binding of HF  molecules 
either in close apposition, or widely separated. A mixture of 12SI-HF (50 rig, 0.05 ~Ci) 1128  AUTOACTIVATION  OF  HAGEMAN  FACTOR 
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Fro.  5.  Plot of the extent of proteolytic cleavage of kaolin-bound )~I-HF (after incubation for 25 
min at 22°C) with remaining HF-procoagulant activity after DFP treatment. The line approaches 
the 0 point of both the x and y axes indicating that the cleavage of HF is directly related to HF 
procoagulant activity. 
and HF (300 ng) in the presence of 0.1 M  Tris pH 7.4 and BSA (5 #g) in a 31-#1 final 
vol was incubated in the presence of various concentrations of kaolin, as noted in Fig. 
6, for 10 min at 37°C. As shown in Fig. 6, at high concentrations, conditions where 
HF molecules would be widely separated on the kaolin surface, only 5-10% of HF 
molecules were cleaved. However, as the kaolin concentration fell and therefore the 
surface area available for binding of HF molecule diminished so that HF molecules 
would be bound closer together on the kaolin surface, the extent of cleavage of z25I- 
HF rose to a maximum of 25% at a kaolin concentration ~ 10-fold higher than the HF 
concentration (wt:wt). Further reduction in the kaolin concentration was accompanied 
by a  fall of the total HF cleavage. In a  parallel experiment done at the same time, 
addition of high mol wt kininogen (520 ng) to the reaction mixture inhibited cleavage 
of HF by about one-half at  the optimal kaolin concentration. Similar results were 
obtained  in  three separate experiments, and  an  identical effect of surface area on 
human HF cleavage has been observed with both glass and kaolin. These findings are 
compatible with the concept that a close molecular association between kaolin-bound 
HF molecules is rquired for cleavage to occur. Such a relationship may be disturbed 
by high molecular weight kininogen. 
Factor XI  Cleavage by  Kaolin-bound  HF and HFa.  To  investigate  whether  kaolin- 
bound single-chain HF was capable of proteolytically cleaving factor XI, or whether 
HFa was required for this function, the following experiment was performed. Single- 
chain mI-HF (250 ng, 0.6 #Ci  +  HF  1.35 #g) was incubated with kaolin (250 #g) in 
the presence of 0.1  M  Tris, pH 7.4, BSA 10 #g in a final reaction vol of 85 #1 for up 
to 50 min to allow cleavage of HF to occur (Fig. 4). At intervals, a  12-#1 aliquot of 
kaolin-bound  zzlI-HF was removed from the reaction mixture and  incubated  for 2 
rain at 37°C with lzsI-factor XI (120 ng, 0.5 #Ci)  in the presence of 0.1  M  Tris, pH 
7.4 (10/zl) and BSA (10 #g). The extent of cleavage of the 131I-HF and 125I-factor XI 
were then measured by analysis on SDS-polyacrylamide gels. 
After 3,  15, and 50 min of incubation, 4,  13, and 34% of the 131I-HF and 5,  11, and 
27% of the  ~2sI-factor  XI molecules were cleaved, respectively. Thus,  the extent of 
proteolytic cleavage of z3tI-HF was paralleled by cleavage of z~I-factor XI, suggesting 
that  for cleavage of factor XI  to occur cleavage of HF was required.  Furthermore, 
single-chain  HF  cleaved in  the  presence of kaolin  apparently became biologically 
active  with  respect  to  factor  XI  cleavage.  The  cleavage  fragments  of factor  XI R.  C.  WIGGINS  AND  C.  C.  COCHRANE  1129 
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FIo.  6.  The effect of varying the kaolin concentration upon the extent of proteolytic cleavage of 
HF (present at  12/~g/ml). The presence of high molecular weight kininogen (0)  in the reaction 
mixture resulted in less cleavage of l~SI-Hageman  factor than when high molecular weight kininogen 
was absent (f-l) from the reaction mixture. 
generated under these conditions were observed at 50,000 and 33,000 daltons, identical 
to those seen in kaolin-activated rabbit plasma (27). 
Proteolytic Cleavage of 12ZI-HF in PrekaUikrein-deficient Plasma.  This experiment was 
performed to investigate the role of HF in the slow proteolytic cleavage of radiolabeled 
HF reported to occur in prekallikrein-deficient plasma (1). Normal human plasma or 
prekallikrein-deficient plasma were depleted to 10% of their normal concentration of 
HF (Methods). These depleted plasmas were also reconstituted by addition of purified 
human HF. x25I-rabbit  HF was added to each plasma and after kaolin activation the 
extent of proteolytic cleavage was measured during a 20-min incubation at 37°C. 
In normal human plasma (control, HF depleted, or HF reconstituted) the extent of 
cleavage of x25I-HF at  1, 2, 8, and 20 min was similar for all three plasmas, being 20, 
63, 72, and 74%, respectively. No cleavage was observed in HF-depleted prekallikrein- 
deficient  plasma.  In  contrast,  control  or  HF-reconstituted  prekallikrein-deficient 
plasma the values were 0, 1, 3, and 10% cleaved after 1, 2, 8, and 20 min, respectively. 
Thus,  HF-depletion  made  no  difference to  the  rate  of cleavage of z25I-HF  in  the 
presence  of  prekallikrein  (normal  human  plasma).  However,  in  the  absence  of 
prekallikrein  (prekallikrein-deficient plasma)  the  slow  cleavage of 125I-HF was  de- 
pendent upon the presence of HF. 
Discussion 
The  observation  that  single-chain  zymogen  HF  became  proteolytically cleaved 
when incubated in the presence of kaolin raised the question of whether HF molecules 
might be capable of proteolytically cleaving other HF molecules. This concept was 
supported  by finding  that  two-chain  82,000-dalton  activated  HF  (a-HFa)  cleaved 
single-chain  HF  in  a  dose-dependent  manner,  and  that  this  occurred much  more 
rapidly in the presence of kaolin. The possibility that this cleavage could have been 
caused by a contaminating protease in the a-HF, preparation is very unlikely because 
soybean  trypsin  inhibitor  inhibited  a-HF~-mediated  cleavage  of HF  to  the  same 
extent as it inhibited a-HF~-mediated factor XI and prekallikrein cleavage. 
Because a-HF~ can cleave HF it was possible that small amounts of a-HFa, or some 
other enzyme, present in the HF preparation might cause the observed cleavage of 
kaolin-bound HF. However, this appears not to be the case, because preincubation of 
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a-HFa-mediated cleavage of  kaolin-bound HF, did not inhibit subsequent HF cleavage 
once the DFP has been removed. 
Single-chain HF is known to slowly take up and be inhibited by DFP (14,  15), and 
can be considered to be an active zymogen, like trypsinogen (28) and Factor VII (29). 
Our observation that long-term incubation of single chain HF prevented cleavage of 
kaolin-bound  HF  to  an  extent  proportional  to  the  inhibition  of its  procoagulant 
activity is quite compatible with the concept that it is single-chain HF, functioning as 
an  active zymogen, which is responsible for the observed cleavage of kaolin-bound 
HF. The alternative hypothesis, that  possible contaminating enzymes (e.g., a-HF~) 
might not be completely inhibited by the DFP treatment cannot be entirely excluded. 
However, the  observation  that  slow cleavage of kaolin-bound  HF  proceeded in  a 
linear rather than an exponential fashion even in the presence of a  10,000-fold molar 
excess  of DFP  (Fig.  3)  makes  this  latter  hypothesis  most  unlikely.  Making  the 
assumption that cleavage under these circumstances does indeed only reflect zymogen 
HF activity (as opposed to the added effect of a-HFa superimposed upon zymogen 
activity  as  occurred in  the  absence  of DFP)  a  calculation  of the  rate  of effective 
zymogen activity can be made (0.1% of the kaolin-bound molecules expressing activity 
per minute). This number is similar to that previously measured for the rate of uptake 
of tritiated DFP by human single-chain HF (14). 
The requirement  for kaolin  for HF cleavage was  not  surprising  because kaolin- 
bound HF is more susceptible to cleavage by other enzymes (30).  The fact that  the 
amount of kaolin was critical suggests that a close molecular association on the kaolin- 
surface was required for cleavage to take place, and provides evidence that it is not 
the binding of HF to kaolin per se which leads to proteolytic cleavage of the molecule, 
but  rather the  interaction between surface-bound HF molecules which  is required 
before cleavage will occur. High molecular weight kininogen which binds to negatively 
charged surfaces inhibited cleavage of HF probably by simply preventing the inter- 
action between HF molecules. 
The concept that  single-chain HF does have enzymatic activity is therefore sup- 
ported  by  its  ability  to  take  up  tritiated  DFP  (14,  15)  and  to  cleave a  synthetic 
substrate  (H-D-phenylalanyl-L-pipecobyl-L-arginine-p-nitroanilide) (31).  In the pres- 
ent study we suggest that  single-chain  HF can also proteolytically cleave other HF 
molecules on a kaolin surface. That this cleavage is associated with the acquisition of 
enhanced activity was demonstrated by finding that cleavage of factor XI by kaolin- 
bound HF directly correlated with  the extent of cleavage of the  HF. This finding 
supports previous observations that emphasize the requirement for limited proteolytic 
cleavage  for  the  activation  of HF  molecules  into  a  form  capable  of generating 
procoagulant activity  (I,  14-19),  but  is  in contrast  to the  findings of Ratnoff and 
Saito (11, 31) who, using Sephadex-Ellagic acid mixtures, observed amidolytic activity 
and activation of Factor XI in the apparent absence of HF cleavage. 
The importance of the concept that  single-chain  HF might  possess  low levels of 
enzymatic activity and be able to cleave other HF molecules, lies in understanding 
the  events  that  take  place  during  contact  activation  of plasma.  The  fact  that 
proteolytic cleavage of HF does occur slowly in kaolin-activated prekallikrein-deficient 
plasma implies that prekallikrein is not essential for the slow activation of HF. Our 
finding that depletion of the HF in prekallikrein-deficient plasma to  10% of normal 
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is dependent upon HF, and that it is unlikely that a  quite different enzyme capable 
of independently activating I--IF is present in kaolin-activated prekallikrein-deficient 
plasma.  These data are compatible with  the concept that  HF can  activate HF in 
prekallikrein-deficient plasma. 
The  question  of what  actually  initiates  this  well-described  reciprocal activation 
between HF and prekallikrein (10, 17-19) when a negatively charged surface is added 
to plasma is not finally answered. However, one possible mechanism is suggested by 
the results of this study, namely, that if two or more HF molecules are bound in close 
association on a  negatively charged surface, proteolytic cleavage of one or both can 
occur. This relatively inefficient mechanism of activating a  few surface-bound HF 
molecules could trigger the explosive reciprocal activation between prekallikrein and 
HF. 
Summary 
Proteolytic cleavage and  activation of isolated,  single chain,  zymogen Hageman 
factor was observed in the presence of kaolin alone. The rate of cleavage of kaolin- 
bound Hageman factor was enhanced 50-fold by the presence of prekallikrein and 
high  molecular weight  kininogen.  The  two-chain  82,000  dalton  form of activated 
Hageman factor (a-HFa) also cleaved kaolin-bound single-chain Hageman factor in 
a  dose-dependent manner,  yielding fragments of 28,000 and,  50,000 dahons under 
reducing conditions. Cleavage of kaolin-bound single-chain Hageman factor was not 
inhibited by preincubation with diisopropylfluorophosphate (12 mM) for 10 min, but 
long-term incubation of Hageman factor with diisopropylfluorophosphate (up to 48 
h)  resulted in  inhibition of cleavage of kaolin-bound  Hageman  factor to an extent 
proportional to the inhibition  of procoagulant  Hageman  factor activity. Hageman 
factor cleavage was  maximal  when  the  kaolin  concentration was  ~10-fold  greater 
than the Hageman factor concentration (wt:wt), and was partially inhibited by high 
molecular weight kininogen. Kaolin-bound Hageman factor cleaved clotting factor 
XI in an amount which correlated with the extent of cleavage of the Hageman factor. 
These findings  are compatible with  the concept that  single-chain  Hageman  factor 
and a-HF, are both capable of cleaving and activating kaolin-bound Hageman factor 
and that a close molecular association of kaolin-bound Hageman factor molecules is 
required for this reaction. 
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